17-44255272-C-T

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000342.4(SLC4A1):​c.1825G>A​(p.Gly609Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000712 in 1,404,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

SLC4A1
NM_000342.4 missense

Scores

15
3
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 7.90

Publications

16 publications found
Variant links:
Genes affected
SLC4A1 (HGNC:11027): (solute carrier family 4 member 1 (Diego blood group)) The protein encoded by this gene is part of the anion exchanger (AE) family and is expressed in the erythrocyte plasma membrane, where it functions as a chloride/bicarbonate exchanger involved in carbon dioxide transport from tissues to lungs. The protein comprises two domains that are structurally and functionally distinct. The N-terminal 40kDa domain is located in the cytoplasm and acts as an attachment site for the red cell skeleton by binding ankyrin. The glycosylated C-terminal membrane-associated domain contains 12-14 membrane spanning segments and carries out the stilbene disulphonate-sensitive exchange transport of anions. The cytoplasmic tail at the extreme C-terminus of the membrane domain binds carbonic anhydrase II. The encoded protein associates with the red cell membrane protein glycophorin A and this association promotes the correct folding and translocation of the exchanger. This protein is predominantly dimeric but forms tetramers in the presence of ankyrin. Many mutations in this gene are known in man, and these mutations can lead to two types of disease: destabilization of red cell membrane leading to hereditary spherocytosis, and defective kidney acid secretion leading to distal renal tubular acidosis. Other mutations that do not give rise to disease result in novel blood group antigens, which form the Diego blood group system. Southeast Asian ovalocytosis (SAO, Melanesian ovalocytosis) results from the heterozygous presence of a deletion in the encoded protein and is common in areas where Plasmodium falciparum malaria is endemic. One null mutation in this gene is known, resulting in very severe anemia and nephrocalcinosis. [provided by RefSeq, Jul 2008]
SLC4A1 Gene-Disease associations (from GenCC):
  • autosomal dominant distal renal tubular acidosis
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary spherocytosis type 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal tubular acidosis, distal, 4, with hemolytic anemia
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • southeast Asian ovalocytosis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • dehydrated hereditary stomatocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cryohydrocytosis
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000342.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant 17-44255272-C-T is Pathogenic according to our data. Variant chr17-44255272-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 235293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC4A1NM_000342.4 linkc.1825G>A p.Gly609Arg missense_variant Exon 15 of 20 ENST00000262418.12 NP_000333.1 P02730-1
SLC4A1XM_005257593.6 linkc.1630G>A p.Gly544Arg missense_variant Exon 13 of 18 XP_005257650.1 P02730-2
SLC4A1XM_011525130.2 linkc.1825G>A p.Gly609Arg missense_variant Exon 15 of 18 XP_011523432.1
SLC4A1XM_011525129.3 linkc.1800+401G>A intron_variant Intron 14 of 18 XP_011523431.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC4A1ENST00000262418.12 linkc.1825G>A p.Gly609Arg missense_variant Exon 15 of 20 1 NM_000342.4 ENSP00000262418.6 P02730-1
SLC4A1ENST00000399246.3 linkc.778-51G>A intron_variant Intron 9 of 14 5 ENSP00000382190.3 A0A0A0MS98

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
7.12e-7
AC:
1
AN:
1404894
Hom.:
0
Cov.:
32
AF XY:
0.00000144
AC XY:
1
AN XY:
693232
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32356
American (AMR)
AF:
0.00
AC:
0
AN:
35800
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25190
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36986
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79596
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49436
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5702
European-Non Finnish (NFE)
AF:
9.25e-7
AC:
1
AN:
1081596
Other (OTH)
AF:
0.00
AC:
0
AN:
58232
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal dominant distal renal tubular acidosis Pathogenic:2
Mar 17, 2025
Undiagnosed Diseases Network, NIH
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 20, 2024
Institute of Immunology and Genetics Kaiserslautern
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG Criteria: PP1_S, PP3, PP5, PM2_P, PM1, PS3; Variant was found in heterozygous state -

not provided Pathogenic:2
Oct 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 609 of the SLC4A1 protein (p.Gly609Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant distal renal tubular acidosis (PMID: 14734552, 28638614, 31672324, 32632909, 34159584). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 235293). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC4A1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC4A1 function (PMID: 14734552, 18524859). For these reasons, this variant has been classified as Pathogenic. -

May 18, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal tubular acidosis Pathogenic:1
Dec 20, 2017
Sydney Genome Diagnostics, Children's Hospital Westmead
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

This individual is heterozygous for the c.1825G>A p.(Gly609Arg) variant in the SLC4A1 gene. The variant has not been reported in any population databases (i.e. ExAC, ESP or dbSNP). This variant has been reported in multiple affected individuals within a family with autosomal dominant distal renal tubular acidosis (dRTA, Rungroj et al 2004 J Biol Chem 279:13833-13838). In vitro expression studies showed that this variant did not affect the function of the protein, but resulted in the mislocalisation of the protein (Rungroj et al 2004). This variant is considered to be likely pathogenic according to ACMG guidelines. -

BLOOD GROUP--DIEGO SYSTEM;C1832168:BLOOD GROUP--FROESE;C1832169:BLOOD GROUP--SWANN SYSTEM;C1861453:Cryohydrocytosis;C1862190:BLOOD GROUP--WRIGHT ANTIGEN;C1862191:BLOOD GROUP--WALDNER TYPE;C1862322:Southeast Asian ovalocytosis;C1970028:Malaria, susceptibility to;C2675212:Hereditary spherocytosis type 4;C5436235:Renal tubular acidosis, distal, 4, with hemolytic anemia;CN280572:Autosomal dominant distal renal tubular acidosis Pathogenic:1
Apr 17, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Southeast Asian ovalocytosis Pathogenic:1
Jan 19, 2023
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.44
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.92
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.96
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Uncertain
0.17
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.78
D
MutationAssessor
Pathogenic
3.7
H
PhyloP100
7.9
PrimateAI
Pathogenic
0.81
D
PROVEAN
Pathogenic
-7.2
D
REVEL
Pathogenic
0.92
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.98
MutPred
0.97
Gain of MoRF binding (P = 0.0145);
MVP
0.97
MPC
1.2
ClinPred
1.0
D
GERP RS
5.8
Varity_R
0.99
gMVP
0.99
Mutation Taster
=8/92
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878853002; hg19: chr17-42332640; API